FindTrial
Sign In

Impact of psychological distress and quality of life after hematopoietic stem-cell transplantation

Impact of psychological distress and quality of life after hematopoietic stem-cell transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067030
Enrollment
Unknown
Registered
2022-12-23
Start date
2022-12-22
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haematologic malignancies

Interventions

Observation group:Psychological Questionnaire

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients who have been diagnosed with hematologic malignancies and have completed hematopoietic stem cell transplantation; 2) Able to understand Chinese correctly and complete the questionnaire independently; 3) Volunteer to participate in this study and agree to sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1) With severe physical disease or cognitive impairment, unable to participate in this study 2) Severe depressive symptoms and suicidal ideation 3) Received psychotherapy within one year

Design outcomes

Primary

MeasureTime frame
FACT-BMT;—

Secondary

MeasureTime frame
GAD-7;PHQ-9;PSQI;PCL-5;ESAS;FACT-F;CD-RISC-10;SSRS;—

Countries

China

Contacts

Public ContactYu Wang

West China Hospital, Sichuan University

919678362@qq.com13880189154

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026